Jane Hollingsworth

Jane Hollingsworth has extensive experience in various roles within the biotechnology and healthcare sectors. Jane currently serves as the Co-Founder and Executive Chair of Eliksa Therapeutics, a company focused on developing novel medicines. Additionally, they are the Chair of the Board of Directors at Diffusion Pharmaceuticals and a member of the Board of Directors at RIBONOVA INC. and Afimmune Ltd.

In the past, Jane was the Managing Partner at Militia Hill Ventures, where they played a key role in launching high-growth life sciences companies. Jane also served as the Vice Chair of the Board of Directors at the University City Science Center and as a member of the Board of Directors at The Kimmel Center for the Performing Arts and Breastcancer.org.

Jane's previous leadership positions include being the Co-Founder and Executive Chair of Spirovant Sciences (formerly Talee Bio) and the Chief Executive Officer/Executive Chair of Immunome, Inc.

Overall, Jane Hollingsworth has demonstrated a strong commitment to advancing healthcare and biotechnology through their leadership roles and contributions to various organizations.

Jane Hollingsworth attended Gettysburg College from an unknown start year to 1980, where they earned a Bachelor of Arts (B.A.) degree. Following this, they enrolled in Villanova University and completed their education in 1986, obtaining a Doctor of Law (J.D.) degree. The field of study for both their degrees is unknown.